Edition:
United Kingdom

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
21 Sep 2018
Change (% chg)

$0.01 (+0.32%)
Prev Close
$3.14
Open
$3.17
Day's High
$3.20
Day's Low
$3.08
Volume
682,010
Avg. Vol
144,104
52-wk High
$4.51
52-wk Low
$2.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.058
Mar '18 0.00 -0.056
FY 2017 Dec '17 0.00 -0.059
Sep '17 0.00 -0.049
Jun '17 0.00 -0.046
Mar '17 0.00 -0.060
FY 2016 Dec '16 0.00 -0.050
Sep '16 0.00 -0.048
Jun '16 0.00 -0.055
Mar '16 0.00 -0.065
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 6 0.38 2.28 0.00 0.00
Year Ending Dec-18 6 0.38 2.28 0.00 8.05
Year Ending Dec-19 6 32.55 55.00 12.70 46.76
Earnings (per share)
Quarter Ending Sep-18 6 -0.08 -0.06 -0.11 -0.06
Quarter Ending Dec-18 6 -0.10 -0.06 -0.15 -0.06
Year Ending Dec-18 6 -0.29 -0.24 -0.38 -0.25
Year Ending Dec-19 6 -0.13 -0.02 -0.35 0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 1.63 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 6.89 15.51 5.00
Price to Tangible Book (MRQ) 6.89 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 41.23 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.13 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 16.48 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 92.65 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 19.43 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,229,030 860,305,024
Net Income/Employee (TTM) -942,463 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.95 -0.15 11.13
Return on Assets - 5 Yr. Avg. -41.17 3.51 12.40
Return on Investment (TTM) -42.00 1.79 14.61
Return on Investment - 5 Yr. Avg. -45.02 2.56 16.13
Return on Equity (TTM) -42.26 3.28 16.33
Return on Equity - 5 Yr. Avg. -47.24 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catalyst Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.92%
# of Holders: 117
Total Shares Held: 53,268,830
3 Mo. Net Change: -2,032,779
# New Positions: 16
# Closed Positions: 19
# Increased Positions: 72
# Reduced Positions: 45
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.